Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc.（ACHV）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
achv · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$13.00
Consensus
$13.00
+137.2% upside
Low
$13.00
Median: $13 · Last Close: $5.48
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.51 | ↑ 0.47% |
1-day model range: $5.45–$5.56. Peak: $5.56 (+0.47%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $6 | +16.6% |
| 2028 | $7 | +27.3% |
| 2029 | $7 | +33.7% |
| 2030 | $8 | +37.4% |
| 2031 | — | +39.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ACHV · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-15 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-05-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-04-01 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-03-05 | Lake Street | Maintains | Buy→Buy |
| 2023-12-12 | Oppenheimer | Maintains | Outperform→Outperform |
| 2023-05-31 | Lake Street | Maintains | Buy→Buy |
| 2023-05-10 | Lake Street | Maintains | Buy→Buy |
| 2023-03-17 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Achieve Life Sciences, Inc. (ACHV) stock. Of the recent 19 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover ACHV.
分析师推荐趋势
ACHV analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$5M
↓ 97.1% YoY
Revenue Next Year
$45M
↑ 901.6% YoY
EPS This Year
$-0.71
EPS Next Year
$-0.46
↓ 35.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ACHV EPS of $-0.71 for the current fiscal year, based on estimates from 6 analysts. The ACHV revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ACHV 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ACHV 的共识目标价为 $13.00（+137.2% 上行空间），分析师共识为 Buy。
ACHV 的短期预测（明日）为 $5.51（+0.47%）。 ACHV 对 2027 年的股价预测均值为 $6。 ACHV 对 2030 年的预测区间为 $7–$8。
Achieve Life Sciences, Inc. 在 NASDAQ 上市，代码 ACHV。ACHV 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
ACHV 预测 · 8 个问题根据 6 位华尔街分析师，ACHV 的 12 个月平均目标价为 $13.00，最高 $13.00、最低 $13.00。若有图表，中位目标价可在上方查看。相对当前价 $5.48，隐含约 +137.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.